These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35264494)

  • 1. Efficacy of Quantitative Susceptibility Mapping with Brain Surface Correction and Vein Removal for Detecting Increase Magnetic Susceptibility in Patients with Alzheimer's Disease.
    Yamaguchi A; Kudo K; Sato R; Kawata Y; Udo N; Matsushima M; Yabe I; Sasaki M; Harada M; Matsukawa N; Shirai T; Ochi H; Bito Y
    Magn Reson Med Sci; 2023 Jan; 22(1):87-94. PubMed ID: 35264494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and Prediction of Early Alzheimer's Disease Using a Machine Learning-based Optimized Combination-Feature Set on Gray Matter Volume and Quantitative Susceptibility Mapping.
    Kim HG; Park S; Rhee HY; Lee KM; Ryu CW; Lee SY; Kim EJ; Wang Y; Jahng GH
    Curr Alzheimer Res; 2020; 17(5):428-437. PubMed ID: 32579502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease.
    Kim HG; Park S; Rhee HY; Lee KM; Ryu CW; Rhee SJ; Lee SY; Wang Y; Jahng GH
    Neuroimage Clin; 2017; 16():429-438. PubMed ID: 28879084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A diagnostic index based on quantitative susceptibility mapping and voxel-based morphometry may improve early diagnosis of Alzheimer's disease.
    Sato R; Kudo K; Udo N; Matsushima M; Yabe I; Yamaguchi A; Tha KK; Sasaki M; Harada M; Matsukawa N; Amemiya T; Kawata Y; Bito Y; Ochi H; Shirai T
    Eur Radiol; 2022 Jul; 32(7):4479-4488. PubMed ID: 35137303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.
    Moon Y; Han SH; Moon WJ
    J Alzheimers Dis; 2016; 51(3):737-45. PubMed ID: 26890777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Susceptibility Mapping of the Hippocampal Fimbria in Alzheimer's Disease.
    Au CKF; Abrigo J; Liu C; Liu W; Lee J; Au LWC; Chan Q; Chen S; Leung EYL; Ho CL; Ko H; Mok VCT; Chen W
    J Magn Reson Imaging; 2021 Jun; 53(6):1823-1832. PubMed ID: 33295658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures.
    Lim IA; Faria AV; Li X; Hsu JT; Airan RD; Mori S; van Zijl PC
    Neuroimage; 2013 Nov; 82():449-69. PubMed ID: 23769915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of quantitative susceptibility mapping with cortical atrophy and brain connectome in Alzheimer's disease: A multi-parametric study.
    Chen H; Yang A; Huang W; Du L; Liu B; Lv K; Luan J; Hu P; Shmuel A; Shu N; Ma G
    Neuroimage; 2024 Apr; 290():120555. PubMed ID: 38447683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSMART: Quantitative susceptibility mapping artifact reduction technique.
    Yaghmaie N; Syeda WT; Wu C; Zhang Y; Zhang TD; Burrows EL; Brodtmann A; Moffat BA; Wright DK; Glarin R; Kolbe S; Johnston LA
    Neuroimage; 2021 May; 231():117701. PubMed ID: 33484853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease.
    Du L; Zhao Z; Cui A; Zhu Y; Zhang L; Liu J; Shi S; Fu C; Han X; Gao W; Song T; Xie L; Wang L; Sun S; Guo R; Ma G
    ACS Chem Neurosci; 2018 Jul; 9(7):1849-1857. PubMed ID: 29722955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative susceptibility mapping demonstrates different patterns of iron overload in subtypes of early-onset Alzheimer's disease.
    Kuchcinski G; Patin L; Lopes R; Leroy M; Delbeuck X; Rollin-Sillaire A; Lebouvier T; Wang Y; Spincemaille P; Tourdias T; Hacein-Bey L; Devos D; Pasquier F; Leclerc X; Pruvo JP; Verclytte S
    Eur Radiol; 2023 Jan; 33(1):184-195. PubMed ID: 35881183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct brain iron profiles associated with logopenic progressive aphasia and posterior cortical atrophy.
    Singh NA; Arani A; Graff-Radford J; Senjem ML; Martin PR; Machulda MM; Schwarz CG; Shu Y; Cogswell PM; Knopman DS; Petersen RC; Lowe VJ; Jack CR; Josephs KA; Whitwell JL
    Neuroimage Clin; 2022; 36():103161. PubMed ID: 36029670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Background field removal technique using regularization enabled sophisticated harmonic artifact reduction for phase data with varying kernel sizes.
    Kan H; Kasai H; Arai N; Kunitomo H; Hirose Y; Shibamoto Y
    Magn Reson Imaging; 2016 Sep; 34(7):1026-33. PubMed ID: 27114339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative susceptibility mapping in β-Amyloid PET-stratified patients with dementia and healthy controls - A hybrid PET/MRI study.
    Tiepolt S; Rullmann M; Jochimsen TH; Gertz HJ; Schroeter ML; Patt M; Sabri O; Barthel H
    Eur J Radiol; 2020 Oct; 131():109243. PubMed ID: 32916411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo compared to Histology.
    Tuzzi E; Balla DZ; Loureiro JRA; Neumann M; Laske C; Pohmann R; Preische O; Scheffler K; Hagberg GE
    J Alzheimers Dis; 2020; 73(4):1481-1499. PubMed ID: 31958079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer's Disease.
    Li D; Liu Y; Zeng X; Xiong Z; Yao Y; Liang D; Qu H; Xiang H; Yang Z; Nie L; Wu PY; Wang R
    J Alzheimers Dis; 2020; 78(1):439-452. PubMed ID: 32986675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals.
    Hagemeier J; Ramanathan M; Schweser F; Dwyer MG; Lin F; Bergsland N; Weinstock-Guttman B; Zivadinov R
    Neuroimage Clin; 2018; 17():530-540. PubMed ID: 29201641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Texture analyses of quantitative susceptibility maps to differentiate Alzheimer's disease from cognitive normal and mild cognitive impairment.
    Hwang EJ; Kim HG; Kim D; Rhee HY; Ryu CW; Liu T; Wang Y; Jahng GH
    Med Phys; 2016 Aug; 43(8):4718. PubMed ID: 27487889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping.
    Chen Y; Liu S; Wang Y; Kang Y; Haacke EM
    Magn Reson Imaging; 2018 Feb; 46():130-139. PubMed ID: 29056394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.